TABLE 4.
The active compounds from medicinal plants most often used in combinations in medical species and probability of predicted antidiabetic mechanisms assitiated with these compounds.
| Medicinal plant/ (abbreviation) | Active compound | Mechanism of action | Pa | Pi |
|---|---|---|---|---|
| Vaccinium myrtillus L. (VM) | Isoorientin | Antidiabetic | 0.806 | 0.005 |
| Vitexin-2"-rhamnosid | α-glucosidase inhibitor | 0.854 | 0.001 | |
| Antidiabetic | 0.767 | 0.005 | ||
| Inositol | Sugar-phosphatase inhibitor | 0.961 | 0.002 | |
| Phaseolus vulgaris L. (PV) | Isoorientin | Antidiabetic | 0.806 | 0.005 |
| Myricetin | Lipid peroxidase inhibitor | 0.836 | 0.003 | |
| β-glucuronidase inhibitor | 0.679 | 0.005 | ||
| Eleutherococcus senticosus (Rupr. & Maxim.) Maxim. (ES) | Syringin | Antidiabetic | 0.684 | 0.007 |
| Hypolipemic | 0.674 | 0.016 | ||
| Eleutheroside E | Sugar-phosphatase inhibitor | 0.887 | 0.005 | |
| Hypericum perforatum L. (HP) | Hyperoside | Antidiabetic | 0.661 | 0.008 |
| Lipid peroxidase inhibitor | 0.976 | 0.002 | ||
| Sugar-phosphatase inhibitor | 0.874 | 0.006 | ||
| α-glucosidase inhibitor | 0.842 | 0.001 | ||
| Aralia elata (Miq.) Seem (AE) | Araloside A | Antidiabetic | 0.639 | 0.009 |
| Hypolipemic | 0.955 | 0.003 | ||
| Insulin promoter | 0.753 | 0.004 | ||
| Araloside B | Lipid peroxidase inhibitor | 0.969 | 0.002 | |
| Hypolipemic | 0.953 | 0.003 | ||
| α-glucosidase inhibitor | 0.932 | 0 | ||
| Araloside C | Hypolipemic | 0.952 | 0.003 | |
| Fragaria vesca L. (FV) | Taxifolin-3-O-arabinofuranoside | Antidiabetic | 0.617 | 0.011 |
| Lipid peroxidase inhibitor | 0.95 | 0.002 | ||
| Antihypercholesterolemic | 0.901 | 0.003 | ||
| Urtica dioica L. (UD) | 2-O-caffeoylmalic acid | Lipid metabolism regulator | 0.836 | 0.005 |
| Quercetin p-coumaroyl glucoside | Lipid peroxidase inhibitor | 0.978 | 0.002 | |
| α-glucosidase inhibitor | 0.729 | 0.001 | ||
| Galega officinalis L. (GO) | Galegine | Sugar-phosphatase inhibitor | 0.632 | 0.047 |
| Glucose oxidase inhibitor | 0.691 | 0.025 | ||
| Phytol | Lipid metabolism regulator | 0.828 | 0.005 | |
| Hypolipemic | 0.68 | 0.015 | ||
| Taraxacum campylodes G.E.Haglund. (TC) | Taraxacin | β-glucuronidase inhibitor | 0.619 | 0.011 |
| Rosa spp. (Rsp) | Lycopene | Sugar-phosphatase inhibitor | 0.794 | 0.017 |
| Lipid metabolism regulator | 0.880 | 0.004 | ||
| Arctium spp. (Asp) | Arctigenic acid | Insulin promoter | 0.579 | 0.017 |
| Vaccinium vitis-idaea L. (VVI) | Hydroquinone | Sugar-phosphatase inhibitor | 0.906 | 0.004 |
| Inulinase inhibitor | 0.690 | 0.004 | ||
| Mentha × piperita L. (MP) | Menthol | Insulin promoter | 0.773 | 0.004 |
| Sugar-phosphatase inhibitor | 0.804 | 0.016 | ||
| Linum usitatissimum L. (LU) | Gallic acid | Sugar-phosphatase inhibitor | 0.941 | 0.003 |
| Glucan endo-1.6-beta-glucosidase inhibitor | 0.933 | 0.002 |